Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Pfisterer

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
American Heart Journal|February 5, 2004
Association of diabetes mellitus and glycemic control strategies with clinical outcomes after acute coronary syndromesDarren K McGuire, L Kristin Newby, Manjushri V Bhapkar, et al.
JAMA|January 30, 2009
BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trialMatthias Pfisterer, Peter Buser, Hans Rickli, et al.
Plos One|January 16, 2019
Competing risks of major bleeding and thrombotic events with prasugrel-based dual antiplatelet therapy after stent implantation - An observational analysis from BASKET-PROVE IIRaban V Jeger, Matthias Pfisterer, Deborah R Vogt, et al.
European Heart Journal|March 8, 2014
Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysisRichard W Troughton, Christopher M Frampton, Hans-Peter Brunner-La Rocca, et al.
Circulation|November 21, 2014
Long-term efficacy and safety of biodegradable-polymer biolimus-eluting stents: main results of the Basel Stent Kosten-Effektivitäts Trial-PROspective Validation Examination II (BASKET-PROVE II), a randomized, controlled noninferiority 2-year outcome trialChristoph Kaiser, Soeren Galatius, Raban Jeger, et al.
The New England Journal of Medicine|November 15, 2011
Thrombin-receptor antagonist vorapaxar in acute coronary syndromesPierluigi Tricoci, Zhen Huang, Claes Held, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
American Heart Journal|February 5, 2004
Association of diabetes mellitus and glycemic control strategies with clinical outcomes after acute coronary syndromesDarren K McGuire, L Kristin Newby, Manjushri V Bhapkar, et al.
JAMA|January 30, 2009
BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trialMatthias Pfisterer, Peter Buser, Hans Rickli, et al.
Plos One|January 16, 2019
Competing risks of major bleeding and thrombotic events with prasugrel-based dual antiplatelet therapy after stent implantation - An observational analysis from BASKET-PROVE IIRaban V Jeger, Matthias Pfisterer, Deborah R Vogt, et al.
European Heart Journal|March 8, 2014
Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysisRichard W Troughton, Christopher M Frampton, Hans-Peter Brunner-La Rocca, et al.
Circulation|November 21, 2014
Long-term efficacy and safety of biodegradable-polymer biolimus-eluting stents: main results of the Basel Stent Kosten-Effektivitäts Trial-PROspective Validation Examination II (BASKET-PROVE II), a randomized, controlled noninferiority 2-year outcome trialChristoph Kaiser, Soeren Galatius, Raban Jeger, et al.
The New England Journal of Medicine|November 15, 2011
Thrombin-receptor antagonist vorapaxar in acute coronary syndromesPierluigi Tricoci, Zhen Huang, Claes Held, et al.
Pageof 8